1. Home
  2. OPTT vs CNTX Comparison

OPTT vs CNTX Comparison

Compare OPTT & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ocean Power Technologies Inc.

OPTT

Ocean Power Technologies Inc.

HOLD

Current Price

$0.19

Market Cap

56.4M

Sector

Utilities

ML Signal

HOLD

Logo Context Therapeutics Inc.

CNTX

Context Therapeutics Inc.

HOLD

Current Price

$0.59

Market Cap

57.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPTT
CNTX
Founded
1984
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
56.4M
57.2M
IPO Year
2006
2021

Fundamental Metrics

Financial Performance
Metric
OPTT
CNTX
Price
$0.19
$0.59
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$1.50
$6.60
AVG Volume (30 Days)
4.5M
2.4M
Earning Date
03-17-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
63.83
17.39
EPS
N/A
N/A
Revenue
$5,861,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$221.57
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.08
N/A
52 Week Low
$0.13
$0.55
52 Week High
$0.72
$3.62

Technical Indicators

Market Signals
Indicator
OPTT
CNTX
Relative Strength Index (RSI) 38.13 33.18
Support Level N/A $0.56
Resistance Level $0.45 $0.70
Average True Range (ATR) 0.02 0.04
MACD 0.00 0.04
Stochastic Oscillator 53.92 37.08

Price Performance

Historical Comparison
OPTT
CNTX

About OPTT Ocean Power Technologies Inc.

Ocean Power Technologies Inc provides intelligent maritime solutions and services that enable safer, cleaner, and more productive ocean operations for the defense and security, oil and gas, science and research, and offshore wind markets. It provides ocean data collection and reporting, marine power, offshore communications, and Maritime Domain Awareness System (MDAS) products, integrated solutions, and consulting services. The company offers its products and services to a wide range of customers, including those in government and offshore energy, oil and gas, construction, wind power, and other industries. The company has operations in North and South America, Europe, Asia and Australia.

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

Share on Social Networks: